Merit Medical Systems (MMSI) : Dalton Greiner Hartman Maher Co reduced its stake in Merit Medical Systems by 36.33% during the most recent quarter end. The investment management company now holds a total of 712,358 shares of Merit Medical Systems which is valued at $17,146,457 after selling 406,534 shares in Merit Medical Systems , the firm said in a disclosure report filed with the SEC on Oct 13, 2016.Merit Medical Systems makes up approximately 1.14% of Dalton Greiner Hartman Maher Co’s portfolio.
Other Hedge Funds, Including , Msi Financial Services Inc boosted its stake in MMSI in the latest quarter, The investment management firm added 400 additional shares and now holds a total of 2,862 shares of Merit Medical Systems which is valued at $68,888.Creative Planning reduced its stake in MMSI by selling 1,042 shares or 46.33% in the most recent quarter. The Hedge Fund company now holds 1,207 shares of MMSI which is valued at $29,234.Fisher Asset Management reduced its stake in MMSI by selling 40,417 shares or 21.75% in the most recent quarter. The Hedge Fund company now holds 145,380 shares of MMSI which is valued at $3,631,592. Merit Medical Systems makes up approx 0.01% of Fisher Asset Management’s portfolio.First Mercantile Trust Co reduced its stake in MMSI by selling 460 shares or 8.16% in the most recent quarter. The Hedge Fund company now holds 5,177 shares of MMSI which is valued at $127,095. Merit Medical Systems makes up approx 0.02% of First Mercantile Trust Co’s portfolio.Simplex Trading boosted its stake in MMSI in the latest quarter, The investment management firm added 164 additional shares and now holds a total of 181 shares of Merit Medical Systems which is valued at $4,444.
Merit Medical Systems closed down -0.76 points or -3.04% at $24.22 with 1,68,049 shares getting traded on Tuesday. Post opening the session at $24.86, the shares hit an intraday low of $24 and an intraday high of $24.88 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Merit Medical Systems reported $0.26 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.24. The company had revenue of $151.07 million for the quarter, compared to analysts expectations of $147.76 million. The company’s revenue was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.25 EPS.
Many Wall Street Analysts have commented on Merit Medical Systems. Merit Medical Systems was Downgraded by Barrington Research to ” Mkt Perform” on Jul 28, 2016.
Merit Medical Systems Inc. (Merit) is a designer developer manufacturer and marketer of medical devices used in an array of interventional and diagnostic procedures across the world. The Company operates in the diagnostic and interventional cardiology interventional radiology interventional gastroenterology interventional pulmonology thoracic surgery interventional nephrology vascular surgery oncology electrophysiology cardiac rhythm management and pain management markets. It operates in segments: cardiovascular and endoscopy. Its cardiovascular segment comprises cardiology and radiology devices which assist in diagnosing and treating coronary arterial disease peripheral vascular disease and other non-vascular diseases and includes the embolotherapeutic products. Its endoscopy segment comprises gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal tracheobronchial and biliary strictures caused by malignant tumors.